New study tests breathing device for neck cancer survivors

NCT ID NCT03502590

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at how well the IGEL laryngeal mask airway works in patients who have had radiation therapy to the neck. These patients are at higher risk of breathing difficulties during anesthesia. Researchers will measure how quickly and successfully the device can be inserted and used to ventilate the patient. The goal is to see if this device is a reliable rescue option for this specific high-risk group.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
IGEL laryngeal mask airway device
What this could lead to
If successful, this could show that the IGEL device is a reliable rescue option for maintaining breathing in high-risk patients with prior neck radiation.
What could go wrong
This is a small, early-stage study with only 62 participants, so results may not apply to all patients. The device may not work as well in this specific group as hoped.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEAD AND NECK CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • St Johns Hospital

    RECRUITING

    Livingston, EH56 6PP, United Kingdom

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.